Illinois workers' comp bill could cut off compounded GLP-1 access

Illinois lawmakers are considering a bill that could change how workers' compensation plans handle compounded drugs, including compounded GLP-1 medications. If you rely on workers' comp coverage after a workplace injury, this matters because it could affect which treatments your plan will pay for. The bill was tracked on Wednesday, August 19, 2026, as part of ongoing legislative activity around GLP-1 access. It has not passed yet, but it is worth watching.

The bill, known as HB 1256, would restrict what compounded drugs Illinois workers' compensation plans can reimburse. Compounded GLP-1s are often used as a lower-cost alternative to brand-name versions, so a restriction like this could remove that option for injured workers who currently rely on it. The proposal does not target GLP-1 medications by name. Instead, it applies to compounded drugs more broadly, which means the effect on GLP-1 access would be a side effect of a wider policy change rather than the main goal. Workers who currently use compounded GLP-1s through their workers' comp plan may want to pay attention to how this bill moves through the legislature, since a shift in reimbursement rules could mean higher out-of-pocket costs or a need to switch treatments.

If you are an Illinois worker currently using a compounded GLP-1 medication through workers' compensation, I would suggest keeping an eye on this bill as it moves through the state legislature. It has not become law yet, and the details of how it would be implemented could still change. Talking with your employer's workers' comp administrator or your prescribing provider now may help you understand what your options would be if the bill passes. We will continue tracking this bill and will update this record as new developments occur.

By Amanda Bonello